INCRETIN-BASED THERAPY AND CANCER: ARE THEY ENEMIES OR ALLIES?

The Role of incretin-based therapies in maintaining glucose homeostasis and management of diabetes mellitus

Saxagliptin beyond glycemic control: a comprehensive review

Beyond Benefits: The Unseen Risks of GLP-1 Receptor Agonists in Recent Trials

ROLE OF THIAZOLIDINEDIONES (TZDs) AND GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONISTS AND ANTAGONOSTS IN TYPE-II DIABETES MELLITUS ON ADULT MALE ALBINO RATS

Role of dipeptidyl peptidase 4 in type 2 diabe tes mellitus

An Overview of the Pharmacogenetics of Sulfonylurea in Type 2 Diabetes Mellitus

Effect of Glucagon Like Peptide 1| (GLP1) Analogues on Obese Egyptians With and Without Diabetes

Effect of Following Guidelines on Pharmacological Managements in Adult Patients with Type 2 Diabetes on Glycemic Outcomes

Role of incretin hormones in type 2 diabetes mellitus